Navigation Links
Caldolor® Clinical Study in Hospitalized Burn Patients Published in Journal of Burn Care & Research
Date:5/16/2011

NASHVILLE, Tenn., May 16, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced that results from a clinical study evaluating the safety and efficacy of Caldolor® (ibuprofen) Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research. The study demonstrated that Caldolor significantly reduces fever in these patients, including those with severe thermal burns. The newly published study also supports the safety of Caldolor as it involved the highest dose and duration of exposure to IV ibuprofen to date, demonstrating that the recommended maximum daily dose of 3200mg/day over five days of treatment was well tolerated.

"Immediate and sustained regulation of body temperature and reduction of fever following a burn injury is critical to patient recovery as well as comfort," said Dr. John T. Promes, principal investigator of the study, Director of Trauma Services and Associate Director for Surgical Education at Orlando Regional Medical Center, Assistant Professor of Surgery at the University of Central Florida College of Medicine, and Clinical Assistant Professor in the Department of Surgery at the Florida State University College of Medicine. "Because oral administration of antipyretics in hospitalized burn patients is often impossible due to sedation, intubation and a variety of factors, IV fever reduction with an agent such as Caldolor is not only convenient but often necessary. Further, as a non-steroidal anti-inflammatory drug (NSAID), Caldolor has the potential to arrest the cascade of inflammation caused by burn injury and thereby alleviate pain in addition to fever."

The prospective, multicenter, randomized, double-blind, placebo-controlled trial was conducted at five U.S. and international sites, including hospital burn units and burn centers. The study evaluated 61 adult
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anesthesiologists Use Caldolor® To Provide Preemptive Pain Control for Surgical Patients at U.S. Medical Centers
2. Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated in Newly Published Clinical Study
3. Newly Published Data Demonstrates Caldolor® Significantly Reduces Pain and Morphine Use in Post-Operative Patients
4. Caldolor® (ibuprofen) Injection Gaining Approval on Formulary at U.S. Medical Centers
5. Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study
6. Latest Clinical Evidence Supports Promising Outlook for Low-Dose Molecular Breast Imaging (MBI)
7. Polaris Group to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan
8. CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study
9. Amira Pharmaceuticals to Present Preclinical Data on AM152 , an LPA1 Receptor Antagonist, at the Annual Meeting of the American Thoracic Society
10. Medco Research Institute® and AssureRx Health Initiate Pilot Program to Evaluate Adoption and Clinical Impact of Pharmacogenetic Testing for Selection of Psychotropic Medications
11. MedQuist Awarded Clinical Documentation Outsource Contract for St. Josephs Hospital Health Center With Focus on Cost Savings, Quality, Peace of Mind
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)...  Luminex Corporation (Nasdaq: LMNX ) today announced that ... 2013 on Monday, February 3, 2014. A press release announcing ... trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... highlights and financial results for the fourth quarter and twelve ...
(Date:1/14/2014)... Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of GMH ... Medical Equipment, Inc. ("Progressive") of Clarion, PA ... were not disclosed. Progressive is a full ... of sleep, mobility, and respiratory products to customers in the ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... ATLANTA, April 7, 2011 Vystar® Corporation ... Natural Rubber Latex (NRL), a patented, all-natural raw ... other non-rubbers found in natural rubber latex, has ... (Logo: http://photos.prnewswire.com/prnh/20100203/CL48049LOGO) Ms. Kearney ...
... Harriet Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, ... of the Company,s therapeutic and preventative HIV vaccines at the ... Convention Center in Washington DC on Thursday, April 14.  Dr. ... a.m., will cover the topic of recombinant viruses as vaccines. ...
Cached Medicine Technology:Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 2Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 3GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 2GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 3
(Date:4/23/2014)... targets an important brain receptor has a dramatic effect ... behavior, a University at Buffalo animal study has found. ... be a novel lead compound for treating cocaine addiction, ... was published as an online preview article in ... compound, RO5263397, severely blunted a broad range of cocaine ...
(Date:4/23/2014)... science, "simple and accessible detection methods that can ... resolution of a single cell inside that population ... engineer Chang Lu. , In the Royal Society ... has announced that he and his coworkers have ... location of a protein ( Chem. Sci. , ...
(Date:4/23/2014)... - In a country as wealthy as the United States, ... seniors do not have access to adequate food due to ... insecure. , Recent research at the University of Illinois ... (NHANES) revealed that the seniors who are dealing with hunger ... "In 2011, 8.35 percent of Americans over age 60 faced ...
(Date:4/23/2014)... Effects of Midlife Occupational and Leisure Time Physical Activity ... physical activity in midlife increases the risk of mobility ... the risk. This is found in a study which ... The study was conducted at the Gerontology Research Center ... , Heavy physical labor is often repetitive, wears the ...
(Date:4/23/2014)... Getting to the bottom of Alzheimer,s disease has ... turns and controversies. In the latest crook in ... insight into the interaction between proteins associated with ... journal ACS Chemical Neuroscience , could have ... K. Surewicz, Krzysztof Nieznanski and colleagues explain that ...
Breaking Medicine News(10 mins):Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2
... , NASHVILLE, Tenn., July 29 HCA Inc. ... 2009. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20050825/CLTH069LOGO ... , Revenues increased 7.2 percent to $7.483 ... $282 million, compared to $141 million in the prior year,s second quarter. , ...
... ... first of its kind in the world , ... Clifton, NJ (PRWEB) July 28, 2009 -- Announcing the first HelpDesk for ... ,Proper clinical research is the only means to bring modern science and technology to diseased ...
... ... training program designed to help medical transcriptionists prepare to take the Registered Medical Transcriptionist ... ... leading online healthcare education company, has released a new online training program designed to ...
... ... the current economy: Vast amounts of vacancies and subleases are driving down initial rents ... ... International Tenant Representative Alliance , the current downturn in the economy provides a ...
... , , , ... more than 49,000 viewers, Family Research Council Action President Tony ... in five key states including Pennsylvania, Arkansas, Alaska, Louisiana, and Nebraska. ... Obama,s plan become reality - rationing and taxpayer funded abortions. ...
... , , EXTON, Pa., July 28 ... report assessing awareness of the Centers for Medicare and ... Medical Directors and Renal Administrators in dialysis units across ... affiliated with large dialysis chains (i.e. Fresenius, DaVita, DCI) ...
Cached Medicine News:Health News:HCA Reports Second Quarter 2009 Results 2Health News:HCA Reports Second Quarter 2009 Results 3Health News:HCA Reports Second Quarter 2009 Results 4Health News:HCA Reports Second Quarter 2009 Results 5Health News:HCA Reports Second Quarter 2009 Results 6Health News:HCA Reports Second Quarter 2009 Results 7Health News:HCA Reports Second Quarter 2009 Results 8Health News:HCA Reports Second Quarter 2009 Results 9Health News:HCA Reports Second Quarter 2009 Results 10Health News:HCA Reports Second Quarter 2009 Results 11Health News:HCA Reports Second Quarter 2009 Results 12Health News:HCA Reports Second Quarter 2009 Results 13Health News:HCA Reports Second Quarter 2009 Results 14Health News:Career Step Launches New Exam Prep Course for Medical Transcription Industry Credential 2Health News:This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 2Health News:This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 3Health News:FRC Action Launches TV Ad Campaign On Government Health Care Takeover 2Health News:New BioTrends Report Explores Anticipated Treatment Pattern Shifts Expected with the Proposed Bundled Payment Structure Planned for 2011 2
Up-tapered output compresses NA to give low NA fiber performance on high NA fiber stock....
One piece, 100% fused silica construction offers low scatter and high efficiency...
... truly lateral, all quartz fiber. The design ... technology for Total Internal Reflection (TIR) at ... output is virtually indistinguishable from an axial ... in a round spot of low divergence. ...
The new series of Steris Power-lift Stirrups incorporate all of the proven clinical benefits of Allen-style booted stirrups: maximum safety for the patient, ease of setup for your staff, impressive v...
Medicine Products: